HCR 578 Ghostwriting in Scientific Authorship
HCR 578 Ghostwriting in Scientific Authorship
Introduction
Ghostwriting in scientific and biomedical studies has become one of the most contentious processes in academic publishing. Ghostwriting is legally acceptable under the copyright’s work-for-hire doctrine. However, it is morally objectionable when it undermines scientific credibility, patient safety, and the integrity of academic research. The difference is two parallel constructs: the legal one, in which ghostwriting is viewed as an intellectual property arrangement, or the ethical one, in which it is viewed as a breach of authorship duty and a misuse of scientific trust. This paper discusses four ethical constructs and two legal constructs of ghostwriting, identifying the tensions they pose to research integrity, scientific credibility, and intellectual property law.
Ethical Constructs of Ghostwriting
Authorship and Responsibility
Authorship in science does not only pertain to credit, but is also about responsibility. According to the International Committee of Medical Journal Editors (ICMJE), authors should be responsible for the integrity and accuracy of their work. Ghostwriting interrupts this relationship by assigning publications to those who did not carry out the research or prepare the manuscript. According to Biagioli (2022), the concept of scientific authorship has traditionally associated reputation with responsibility, in contrast to the copyright law that values ownership. This leads to a scenario where authors mentioned in papers cannot defend, elaborate, or accept the responsibility of claims made, which compromises trust.
Conflict of Interest and Transparency
Corporate agendas can be marketed through ghostwritten articles, particularly in the pharmaceutical industry, where companies pay to publish positive articles about their products. Sismondo (2009) reveals the manner in which drugs are strategically marketed by ghostwriting in the name of independent scholarship. When physicians read ghostwritten work, they assume they are reading objective research, when in reality they are reading a marketing instrument. This is shown by the example of Merck and its Vioxx, whereby 900,000 copies of a ghostwritten article were mailed to physicians without their knowledge of its corporate sponsorship (Smith, 2024).
Plagiarism and Misrepresentation
Ghostwriting, though not in the conventional sense of copying, acts as a reverse plagiarism in that it gives credit to the not-doer and erases the doer. Other institutions, such as Penn Medicine, associate ghostwriting with plagiarism because it conceals both authorship and responsibility. This distortion makes science less plausible and may even harm science on which medical practice is grounded.
Impact on Scientific Integrity and Public Trust
Ghostwriting undermines the accuracy of the scientific record ethically. In cases when doctors, politicians, and patients are unable to differentiate between honest research and advertising made by the company, it puts the validity of science in question. Ethical constructs are concerned with truth, transparency, and accountability. Ghostwriting diminishes the value of science by deceiving practitioners and consequently jeopardizes health in society. This was evident in the Wyeth hormone replacement therapy case, where ghostwritten articles falsely emphasized drug safety and resulted in real clinical consequences.
Legal Constructs of Ghostwriting
Work-for-Hire Doctrine (Copyright Law)
In the United States, ghostwriting is acceptable under the work-for-hire doctrine as dictated by copyright law. In a scenario where a company contracts a writer to create content, the legal author and copyright holder is the company at the time of creation (Biagioli, 2022). This renders ghostwriting a simple legal agreement, according to intellectual property law, similar to speechwriting or the creation of contractual content. In this perspective, there is no trickery: possession is retained by the paying body.
Patent and Market Exclusivity Framework (Hatch-Waxman Act)
The Hatch-Waxman Act of 1984 influenced the US drug patents and generic entry. It established the Abbreviated New Drug Application (ANDA) process, extensions of patent terms, data exclusivity, and incentives such as 6-month exclusivity of the first generic challenger. It also established safe harbor regulations and a 30-month stay in patent litigation. Although the Act balanced both innovation and competition, ghostwritten articles would tend to increase brand exclusivity. This is a legal but unethical practice that poses questions about misleading advertising and underestimated risks.
Examples:
- Wyeth employed ghostwriters to market hormone therapy, which made the advantages appear larger and the risks smaller. The company was using copyright and derivative provisions under which they were publishing such articles under the names of academic authors, which was later brought to light in court.
- In the Vioxx case, Merck hired ghostwriters to reprint articles and defended the practice as a legal right. However, ethics became a concern when hidden heart risks emerged, creating a conflict between corporate rights and the duty to disclose risks.
Should Ethical Constructs Impact Intellectual Property Laws?
The debate over ghostwriting hinges on whether intellectual property law can be influenced by ethical standards of writing. Currently, legal standards are not the same as ethical standards; copyright law does not oppose ghostwriting, although it is condemned by scientific communities.
Argument For Impact
Indeed, the intellectual property laws must be guided by moral constructs, particularly when it comes to issues that touch on the health of the wider population. The current copyright law is founded on ownership as opposed to responsibility. The legislation enables companies to evade the issue of ghostwriting by ignoring the authorship concept. The following are two examples of why reform is needed:
Wyeth’s ghostwriting strategy: Copyright allowed the company to repackage corporate manuscripts using the names of other academics, turning advertising into scientific text. This could have been stopped by stronger laws that linked copyright with disclosure requirements.
Vioxx litigation: Merck was not violating the law by distributing ghostwritten reprints, but it was hiding the dangers of the drug and was misleading doctors and patients. Assuming that the ethical requirements of intellectual property laws were applied to the suggested intellectual property legislation, there might have been an indication that the ghostwritten reprints were promotional and not scientific.
Argument Against Impact
Nevertheless, critics believe that not all ethical norms should be translated into law. The intellectual property law plays a minimally restricted role in controlling ownership and incentives of innovation. The broadening of police ethical matters can be a stretch of the law and can have chilling effects on legitimate commissioned writing, like technical editing or collaborative writing (FDA, 2019). Rather, publication standards, retraction policy, and institutional sanctions should be used to address the issue of ethics violations by academic and professional institutions such as the International Committee of Medical Journal Editors (ICMJE) and the World Association of Medical Editors.
Reasoned Conclusion
The current intellectual property law does not assume the disclosure of ghostwriting, as most companies obtain copyright and credit rights on a contractual basis. Ghostwriting is also legal and prevalent, but the claim of moral rights prevents false attribution. Hybrid regulation would be a middle ground between disability and disclosure of corporate authorship and marking ghostwritten work sponsored. Misconduct would then be dealt with by ethical or professional bodies, and this will make the law more understandable and enhance transparency between what is ethical and what is legal.
Conclusion
Ghostwriting is the area that is on the edge of legal and ethical questions. It is lawfully supported by the copyright law and the pharmaceutical market regulations, which are the work-for-hire doctrine and the Hatch-Waxman law. It is ethically corrupt, it distorts authorship, it conceals conflicts of interest, and it demeans belief in science. This kind of paradox between those two constructs is a menace to the integrity of the science and also to the well-being of the population. Ghostwriting is not a crime per the intellectual property law, though it must be reported ethically, particularly in medicine, where patient care is based on evidence. Ghostwriting conceals itself as a science and threatens the lives of people. Protection of scientific integrity and human health must be addressed either legally, ethically, or through the application of both.
References
Biagioli, M. (2022). Ghosts, brands, and influencers: Emergent trends in scientific authorship. Social Studies of Science, 52(3), 463–487. https://doi.org/10.1177/03063127221095046
Sismondo, S. (2009). Ghosts in the machine: Publication planning in the medical sciences. Social Studies of Science, 39(2), 171–198.
Smith, R. (2024). The trouble with medical journals. CRC Press.
U.S. Food and Drug Administration. (2019). Public Warning and Notification of Recalls Under 21 CFR Part 7, Subpart C: Guidance for Industry and FDA Staff.
HCR 578 Ghostwriting in Scientific Authorship
